The Value of Cancer Treatment Today

PhRMA

In recent decades, tremendous progress has been made in the fight against cancer. Continued research has expanded our knowledge of how the disease develops and how to target medicines for specific cancer types – resulting in more effective therapies for patients. Biopharmaceutical companies are developing 836 medicines and vaccines for cancer, all of which are in clinical trials or awaiting review by the U.S. Food and Drug Administration (FDA).

 

Key Facts About Cancer

 

Latest From TheBlog

Medicare Monday: Don’t forget! Medicare open enrollment ends Wednesday

By Nicole Longo on December 5, 2016 at 09:00 AM

World AIDS Day 2016: A decade of scientific innovation

By Andrew Powaleny on December 1, 2016 at 09:00 AM

10 years of living and managing type 1 diabetes; lessons learned

By Guest Contributor on November 30, 2016 at 12:00 PM

ICER glosses over significant progress in MS treatment

By Holly Campbell on November 30, 2016 at 09:00 AM